Novo Nordisk Canada and Mayor Crombie Lace Up for Mississauga Marathon

In-person running at the Mississauga Marathon returns after a two-year hiatus due to the COVID-19 pandemic, encouraging local residents to get active and take part in community health initiatives

MISSISSAUGA, ON, April 27, 2022 /CNW/ - Mississauga Mayor Bonnie Crombie will be lacing up her runners to join top local researchers and residents in the 5k Hazel Walk/Run as part of the Mississauga Marathon, joining the Type 2 Diabetes Prevention Dream Team to promote healthy living and fight Type 2 diabetes.

Novo Nordisk Canada Inc. (CNW Group/Novo Nordisk Canada Inc.)

Novo Nordisk Canada and Mayor Crombie Lace Up for Mississauga Marathon (CNW Group/Novo Nordisk Canada Inc.)

Events for the annual Mississauga Marathon will take place in-person from Saturday April 30^th to Sunday May 1^st.  Novo Nordisk is proud to sponsor the 5k Hazel Walk/Run that will start in Port Credit by the iconic lighthouse and finish at Lakefront Promenade Park. The return of the marathon brings Mississauga together in an open, safe environment to encourage healthy living and healthier cities.

Peel Region – which includes Mississauga – has one of the highest incident rates of type two diabetes in Ontario.¹ About 1 in 10 adults in Peel are currently living with diabetes or prediabetes and that number is projected to rise to 1 in 6 by 2025.² With warmer weather upon us and the return of the in-person Mississauga Marathon, residents are encouraged to get active and help bend the curve of type 2 diabetes, one step at a time.

"We're so excited to welcome runners back to our annual Mississauga Marathon this weekend, as it's a wonderful opportunity to bring the community together for a great cause, while encouraging healthy, active lifestyles," says Mississauga Mayor Bonnie Crombie. "Just last year, the City of Mississauga proudly joined Cities Changing Diabetes, a global program to address the rise of type 2 diabetes in cities, and the Mississauga Marathon is a great example of how we can work together to promote healthy living among the community and reduce the risks of type 2 diabetes. I encourage Mississauga residents of all ages and abilities to get active and join us at the Mississauga Marathon."  

While diabetes impacts close to 11 million Canadians³, type 2 diabetes has become a public health concern in Mississauga as it places a significant burden on quality of life and on the healthcare system. The projected healthcare cost of diabetes in Peel Region is estimated to be $689 million in 2024.⁴

"With our head office in Mississauga, and many colleagues residing in Canada's seventh largest city; Novo Nordisk Canada is proud to sponsor the Mississauga Marathon's 5k Hazel Run/Walk. This partnership directly aligns with our ongoing commitments in driving change and defeating diabetes," says Adam Marsella, Director of External Affairs, Novo Nordisk Canada. "Our partnership with the City of Mississauga and the Mississauga Marathon is an important step to help reduce the prevalence of type 2 diabetes and other chronic conditions."

For more information on the Mississauga Marathon or to register, visit https://www.mississaugamarathon.com/.

For more information on Cities Changing Diabetes Mississauga program, visit https://www.mississauga.ca/projects-and-strategies/city-projects/cities-changing-diabetes-programme/

About Type 1 and Type 2 diabetes
Type 1 diabetes is a genetic disease in which the pancreas does not produce any insulin. Insulin is an important hormone that helps the body control the level of glucose (sugar) in your blood.⁵   Type 2 diabetes is a disease in which your body cannot make enough insulin (a hormone that helps control the amount of glucose or sugar in your blood) or does not properly use the insulin it makes. It is caused by several different risk factors and accounts for 90% of diabetes cases in Canada. ⁶

About Novo Nordisk
Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat diabetes and other serious chronic diseases such as obesity and rare blood and endocrine disorders. We do so by pioneering scientific breakthroughs, expanding access to our medicines and working to prevent and ultimately cure disease. Novo Nordisk employs about 42,700 people in 80 countries and markets its products in around 170 countries.

For more information, visit novonordisk.ca, or @NovoNordiskCA on Twitter.

	_____________________________
	^1Geoff Koehler, "What's behind Peel's high diabetes rate? Urban planning and ethnic backgrounds" (University of Toronto, 2014): https://www.utoronto.ca/news/whats-behind-peels-high-diabe-tes-rate-urban-planning-and-ethnic-background.  Accessed March 2022.
	^2 Region of Peel. Diabetes Atlas for the Region of Peel. Retrieved from https://www.peelregion.ca/health/resources/diabetes-atlas/full-report.pdf. Accessed March 2022.
	^3 Diabetes Canada. Diabetes in Canada. Retrieved from https://www.diabetes.ca/DiabetesCanadaWebsite/media/Advocacy-and-Policy/Backgrounder/2020_Backgrounder_Canada_English_FINAL.pdf . Accessed March 2022.
	^4 Peel Region, The Changing Landscape of Health in Peel (2019): https://www.peelregion.ca/health/resources/pdf/CHSR-changing-landscape-health-peel-full-report.pdf. Accessed March 2022.
	^5 Diabetes Canada. About type 1 diabetes. Retrieved from https://www.diabetes.ca/about-diabetes/type-1. Accessed April 2022.
	^6 Diabetes Canada. About type 2 diabetes. Retrieved from https://www.diabetes.ca/about-diabetes/type-2. Accessed April 2022

SOURCE Novo Nordisk Canada Inc.

Media: Jaclyn Crawford, 647 201 6817, [email protected]; Rob McEwan, 416 454 4515, [email protected]